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Purpose: To evaluate the relationships between insulin sensitivity (IS), body fat   accumulation, 
and aerobic capacity in middle- to older-aged Japanese participants with visceral adiposity.
Participants and methods: Aerobic capacity was measured during an incremental ramp 
exercise test. Computed tomography was used to measure visceral (VFA) and subcutaneous 
(SFA) fat area, the fat in liver-to-spleen ratio (L/S), and low-density skeletal muscle area 
(LDMA). IS was assessed using euglycemic-hyperinsulinemic clamps.
Results: A total of 11 males and 9 females, age 58 ± 9 years (mean ± standard deviation), 
body mass index 29 ± 4.1 kg/m2, and VFA 190 ± 53 cm2 participated in this study. In unadjusted 
models, VFA, LDMA, and L/S were significantly correlated with IS, which remained in adjusted 
models for LDMA and L/S, but not for VFA. In multiple stepwise regression analysis including 
sex, age, body fat, VFA, SFA, alcohol consumption, and aerobic capacity (oxygen uptake at 
the lactate threshold), L/S, and LDMA accounted for 70% of the total variance in IS. Percentage 
body fat and SFA, but not VFA, were significantly correlated with high molecular-weight 
adiponectin levels (r = 0.58, P , 0.01 and r = 0.54, P , 0.05, respectively). IS and L/S were 
significantly and negatively correlated with tumor necrosis factor-α (r = -0.67 and -0.63, 
respectively; both P , 0.01) and plasminogen activator inhibitor-1 (r = -0.58, P , 0.01 and -0.52, 
P , 0.05, respectively), whereas LDMA was not.
Conclusion: These findings indicate that ectopic fat deposition in the liver and skeletal muscle 
may be associated with peripheral IS independently of body fat accumulation and aerobic 
capacity in middle- to older-aged Japanese individuals with visceral adiposity. Because of the 
small sample size, additional larger studies are needed to provide further insight into these 
preliminary findings.
Keywords: aerobic capacity, fat in liver, lipid-rich skeletal muscle, visceral fat, subcutaneous 
fat, peripheral insulin sensitivity
Introduction
Recent studies have shown that ectopic fat deposition in the liver1–3 and skeletal 
muscle4,5 is negatively correlated with insulin sensitivity (IS), even in relatively lean 
individuals. Obese patients often exhibit fat accumulation in the liver and skeletal 
muscle, regardless of visceral fat (VF) accumulation.1,6 This suggests that ectopic fat 
in either organ may be involved in the pathogenesis of declining IS.
Decreased aerobic capacity is correlated with metabolic risk7 and declining IS,8 
independently of VF and subcutaneous fat (SF). Similarly, a correlation between 
aerobic capacity and liver fat has also been reported.6,9 These findings suggest that 
VF, fat accumulation in the liver and skeletal muscle, and aerobic capacity each exert 
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To evaluate the strength of the correlation between these 
parameters and IS, it is necessary to measure all of the 
parameters in the same participants. To our knowledge, only 
one study has measured IS in relation to VF, SF, liver fat, 
intramyocellular fat, and aerobic capacity.10 That study of 
Finnish subjects showed that liver fat was strongly correlated 
with IS rather than with intramyocellular fat. Furthermore, 
patients with metabolic syndrome had significantly higher 
liver fat content than did those without metabolic syndrome, 
whereas there was no significant difference in intramyocel-
lular fat between these groups. However, such information 
has been lacking with regard to the Japanese population.
Such information is needed because Japanese individuals 
show a higher risk for type 2 diabetes at lower levels of 
obesity as compared with Caucasian individuals. For 
  example, Kadowaki et al reported that Japanese individuals 
had greater VF area (VFA) than did Caucasians.11 
  Furthermore, the incidence of fatty liver was higher, despite 
the lower body mass index (BMI), in Japanese individuals 
than in   Caucasians.12 Thus, these data suggest there are ethnic 
differences in fat distribution between Asians (Japanese) and 
Caucasians. Despite these findings, the relationship between 
ectopic fat deposition in the liver or skeletal muscle and IS 
in Japanese individuals is still unclear.
Therefore, in an attempt to address this limited knowl-
edge, we performed this preliminary study to explore the 
relationship between peripheral IS, body fat accumulation, 
and aerobic capacity in middle- to older-aged Japanese 
  participants with visceral adiposity.
Participants and methods
Participants
Participants were Japanese individuals .40 years old with a 
waist circumference .85 cm (males) or .90 cm (females) 
according to the Japanese diagnostic criteria for metabolic 
syndrome in adults, and VFA . 100 cm2 according to the 
Japanese clinical criteria for visceral adiposity. The subjects 
who were enrolled in this study were not taking any medica-
tions affecting IS. Furthermore, individuals who were taking 
medications likely to affect glucose or lipid metabolism were 
excluded from this study. We confirmed that none of the subjects 
had liver disease, other than fatty liver, based on their past 
medical histories. Whereas, diabetes mellitus was diagnosed 
by demonstrating both of the following: glycosylated hemo-
globin (HbA1c) $ 6.5% and fasting plasma glucose $126 mg/dL. 
This study was advertized in a local newspaper.
All of the participants completed a questionnaire related 
to their lifestyle, including their own and their families’ 
  medical history, alcohol consumption, cigarette smoking, and 
physical activity. Moderate alcohol intake was defined as 
consumption of .20 g/day, based on the questionnaire’s evalu-
ation of the quantity and frequency of alcohol   consumption. 
Daily alcohol consumption was estimated as a continuous 
variable (g/day) based on the assumption that the concentra-
tions of alcohol were 5% for beer, 12% for wine, 40% for 
liquor, and 25% for shochu (distilled spirit).
All of the participants gave informed consent, and the 
study was approved by the Ethics Committee of Fukuoka 
University and Kyushu Clinical Pharmacology Research 
Clinic, Fukuoka, Japan.
Outcome parameters
The subjects were studied on four separate occasions for the 
purposes of 1) screening, 2) a body composition and exercise 
test, 3) computed tomography (CT) (Toshiba Multi-CT 
Aquilion TSX-101A Scanner; Toshiba Medical Systems, 
Tokyo, Japan) examination, and 4) serum biochemical 
  analysis and a euglycemic-hyperinsulinemic clamp. All 
measurements were performed within 4–8 weeks. The sub-
jects were instructed to maintain their habitual lifestyle 
(exercise and food intake) during the study period. The 
subjects were asked to avoid strenuous physical activity for 
2 days before each visit. The clamp and exercise tests were 
performed at least 1 week apart.
Anthropometry and body composition
All anthropometric measurements were made with partici-
pants wearing only light undergarments. Height was mea-
sured using a stadiometer to the nearest 0.1 cm. Bodyweight 
was measured using a calibrated balance beam scale (Shinko 
Denshi Vibra Co. Ltd, Tokyo, Japan) to the nearest 0.01 kg 
and was rounded to one decimal place. Body fat percentage 
(%FAT) was estimated using the Brozek formula with body 
density, which was estimated by hydrostatic weighing with 
correction for the residual lung volume measured by simul-
taneous O2 re-breathing.13 Fat-free mass was calculated using 
the formula: fat-free mass = bodyweight - (bodyweight × 
%FAT/100). Body surface area (BSA) was calculated 
using a formula reported by Fujimoto et al,14 as BSA = 
height (cm)0.66 × bodyweight (kg)0.444 × 88.83. All anthro-
pometric and body composition data were determined in the 
morning after a 12-hour overnight fast.
computed tomography
CT was performed at a peak voltage of 135 kVp, 400 mA, 
and a scan time of 0.5 seconds with a 512 × 512 matrix. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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The tested scan field of view was set at 400 mm for six 
  participants and 500 mm for 14 participants according to the 
anthropometry of each subject. VFA and SF area (SFA) were 
assessed at the L4–L5 intervertebral disc space. Six 2-mm-
thick scans were obtained to reconstruct a 10-mm-thick 
volume dataset, which was used to calculate VFA and SFA 
using image analysis software (M900PRIMAL; Ziosoft Inc, 
Tokyo, Japan).
CT was also used to measure the mid-thigh muscle area 
and quantify low-density skeletal muscle area (LDMA), 
a marker of lipid-rich skeletal muscle. Six 2-mm-thick scans 
were obtained at the midpoint between the anterior iliac 
crest and the superior border of the patella of the thigh to 
  reconstruct a 10-mm-thick volume dataset.
The fat in liver-to-spleen ratio (L/S) was determined as 
an index of liver fat, as previously described.15 Briefly, six 
contiguous abdominal CT scans (2 mm thick) from T12 to 
L1 were obtained to reconstruct a 10-mm-thick volume 
dataset. LDMA and L/S were determined from the calculation 
of the Hounsfield units (HU) values using CT image analysis 
software on a Macintosh computer (OsiriX ver 3.3; OsiriX 
Foundation, Geneva, Switzerland). LDMA was quantified 
within a 0–30 HU attenuation window.16 The mean HU values 
of the liver and spleen were also obtained to determine L/S.15 
All participants fasted for at least 3 hours, but were allowed 
water, before the CT examination.
euglycemic-hyperinsulinemic clamp
After an overnight fast, each participant underwent a 2-hour 
euglycemic-hyperinsulinemic clamp. To maintain a plasma 
insulin level of 100 µU/mL and to suppress endogenous 
hepatic glucose output, insulin was infused at 40 mU/m2/min. 
To maintain the plasma glucose level at 100 mg/dL, a con-
tinuous, adjustable infusion of 20% glucose solution was 
given and adjusted according to plasma glucose concentra-
tions, which were measured every 5 minutes. IS was assessed 
as the metabolic clearance rate (MCRG/IC), which was 
expressed as the ratio of the glucose disposal rate to the 
plasma glucose and insulin concentrations,17 at 2 hours after 
starting the clamp.
Serum biochemical analysis
Blood samples were obtained from an antecubital vein in the 
morning after a 12-hour overnight fast. Biochemical param-
eters included: glucose (hexokinase ultraviolet assay kit; 
Shino-Test, Tokyo, Japan), insulin (chemiluminescent 
enzyme immunoassay [CLEIA] kit; Fujirebio, Tokyo, Japan), 
HbA1c (latex agglutination assay kit; Fujirebio), triglyceride 
(enzymatic kit; Sekisui Medical, Tokyo, Japan), HDL and 
LDL cholesterol (direct assay; Sekisui Medical), free fatty 
acids (enzymatic kit; Eiken Chemical, Tokyo, Japan), 
  interleukin (IL)-6 (CLEIA kit; Fujirebio), high-sensitivity 
C-reactive protein (hsCRP) (nephelometry kit; Siemens 
Healthcare Diagnostics, Berlin, Germany), high molecular 
weight (HMW)-adiponectin (enzyme-linked immunosorbent 
assay [ELISA]; Fujirebio), tumor necrosis factor (TNF)-α 
(ELISA, R&D Systems, Minneapolis, MN), and plasminogen 
activator inhibitor (PAI)-1 (latex photometric immunoassay; 
Mitsubishi Chemical Medicine, Tokyo, Japan). All serum 
biochemical analyses were conducted by an independent 
company (SRL, Inc., Tokyo, Japan). HbA1c level (%), rep-
resented as the National Glycohemoglobin Standardization 
Program value, was calculated from the level of HbA1c 
derived by the Japan Diabetes Society value plus 0.4%.
Aerobic capacity
Aerobic capacity was assessed by the oxygen uptake at the 
lactate threshold (LT), determined using an incremental 
exercise test on a bicycle ergometer (Rehcor; Lode BV, 
Groningen, The Netherlands). The work rate was initially 
set at 10 watts for 4 minutes at a frequency of 60 rpm and 
was then continuously increased at 15, 10, or 8 watts/min 
during the ramp test. The increment was determined from 
the sex, age (men ,65 years old, 15 watts; men $65 years 
old, 10 watts; women ,65 years old, 10 watts; women $65 
years old, 8 watts), or medical supervision. The test was 
continued until subjective exhaustion was achieved. 
  Respiratory gas analysis was conducted using the mixing 
chamber method to evaluate the volume of expired air, and 
the O2 and CO2 fractions were analyzed by mass spectrom-
etry (ARCO-1000; Arco Systems, Chiba, Japan). The LT 
was divided by fat-free mass. Earlobe blood samples were 
obtained every 30 seconds to measure lactate levels. Blood 
samples (20 µL) were   collected in blood collection tubes 
and analyzed using a Biosen 5040-lactate analyzer (EKF 
Diagnostik, Barleban, Germany).
Physical activity
The subject’s daily step counts were measured by a vali-
dated piezoelectric uniaxial accelerometer (Lifecorder EX; 
Suzuken Co, Ltd, Nagoya, Japan).18 The number of steps 
taken per day was determined by accelerometry signals due 
to body movements. The subjects wore the accelerometer on 
their waist throughout the day, except while sleeping or 
bathing, every day for at least 2 weeks. All measured vari-
ables were averaged over the 7 consecutive days of the Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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measurement period to assess physical activity in free-living 
conditions.
Statistical analysis
Data are expressed as means ± standard deviation. Pearson’s 
correlation coefficients among MCRG/IC, %FAT, VFA, 
SFA, LDMA, L/S, and biochemical markers were calculated 
after applying Fisher’s r-to-z transformation. MCRG/IC and 
  biochemical markers with nonnormally distributed values 
were logarithmically transformed to approximate normal 
  distributions. We believe that normalization of these factors 
is necessary for comparisons among all of the parameters, 
considering dimensional inference and units. For example, 
blood samples are usually normalized by the volume 
of blood, while anthropometric measures are normalized by 
body size. Therefore, VFA and SFA were normalized by 
BSA, and LDMA was normalized for the mid-thigh area. 
Partial correlation coefficient analysis was performed to 
determine independent relationships among VFA, L/S, 
LDMA, and alcohol consumption. Forward stepwise linear 
regression analysis was used to determine the effects of age, 
sex, fat accumulation (%FAT, VFA, SFA, LDMA, and L/S), 
estimated alcohol consumption (g/day), and LT as indepen-
dent variables on IS. Sex was coded as male = 1 and 
female = 2. Values of P , 0.05 were considered statistically 
significant. All statistical analyses were performed using SPSS 
software (version 12.0; SPSS Inc., Chicago, IL, USA).
Results
Participants
A total of 56 participants responded to the advertisements. 
Of these, 20 middle- to older-aged individuals (age 
43–73 years; BMI 22.9–38.5 kg/m2; 11 males and 9 females) 
met the prespecified inclusion criteria (waist circumfer-
ence .85 cm [males] or .90 cm [females]; VFA . 100 cm2; 
not taking medications likely to affect IS) and underwent a 
euglycemic–hyperinsulinemic clamp, and were thus included 
in this study. None of the subjects had diabetes mellitus 
(5.7% ± 0.4% and 111 ± 14 mg/dL of HbA1c and fasting 
plasma glucose on average) or liver disease. The character-
istics of the participants are summarized in Table 1. The 
average daily step count was 6486 ± 2637 steps/day, indicat-
ing that these participants were mostly sedentary. Two men 
consumed moderate amounts of alcohol (.20 g/day) for at 
least the preceding year. Although the mean time between 
the first and last visit was 40.1 ± 6.8 days, there was no change 
in bodyweight between the first and last visits (75.8 ± 14.7 versus 
75.7 ± 14.3 kg, respectively; P = 0.78).
correlations between indices  
of fat accumulation
The correlations between indices of body fat accumulation 
(%FAT, VFA, SFA, LDMA, and L/S) are shown in Table 2. 
Both %FAT and SFA were significantly correlated with 
Table 1 Participant characteristics
All participants Males Females
Sex (males/females) 11/9
Age (y) 58 ± 9 53 ± 8 64 ± 8a
height (cm) 161.1 ± 10.5 169.0 ± 6.1 151.3 ± 4.4b
BSA (m2) 1.76 ± 0.21 1.89 ± 0.14 1.59 ± 0.16b
Weight (kg) 75.7 ± 14.7 83.0 ± 12.2 66.9 ± 12.9c
BMi (kg/m2) 29.0 ± 4.1 29.0 ± 3.8 29.1 ± 4.7
%FAT (%) 33.2 ± 7.7 27.7 ± 5.2 40.0 ± 3.5b
VFA (cm2) 190 ± 53 205 ± 52 172 ± 52
VFA/BSA (cm2/m2) 108 ± 24 108 ± 23 107 ± 27
SFA (cm2) 264 ± 99 216 ± 84 323 ± 85c
SFA/BSA (cm2/m2) 152 ± 57 113 ± 35 200 ± 37b
LDMA (cm2) 33.7 ± 15.7 32.5 ± 15.3 35.0 ± 17.0
LDMA/mid-thigh  
area (cm2/cm2)
0.07 ± 0.02 0.06 ± 0.02 0.07 ± 0.02
L/S ratio 1.11 ± 0.23 1.05 ± 0.25 1.18 ± 0.19
glucose (mg/dL) 111 ± 14 115 ± 17 107 ± 10
insulin (µiU/mL) 11.4 ± 3.7 12.3 ± 3.2 10.4 ± 4.2
hbA1c (%) 5.7 ± 0.4 5.5 ± 0.3 5.8 ± 0.4
Triglyceride  
(mg/dL)
120 ± 73 153 ± 84 85 ± 35c
hDL (mg/dL) 45 ± 12 42 ± 10 48 ± 13
LDL (mg/dL) 116 ± 30 120 ± 24 111 ± 36
FFA (µeq/L) 1.5 ± 1.5 1.7 ± 2.1 1.3 ± 0.3
hscrP (ng/mL) 820 ± 776 1062 ± 937 523 ± 392
iL-6 (pg/mL)d 1.7 ± 0.8 1.5 ± 0.7 1.9 ± 0.8
TnFα (pg/mL) 1.4 ± 0.7 1.3 ± 0.8 1.4 ± 0.5
hMW adiponectin  
(µg/mL)
3.9 ± 2.3 2.7 ± 1.2 5.5 ± 2.5a
PAi-1 (ng/mL) 30.8 ± 12.9 35.1 ± 14.8 25.4 ± 7.8
Mcr (mL/kg/min) 4.1 ± 1.2 4.1 ± 1.4 4.2 ± 1.0
Mcrg/ic  
(mL/kg/min per  
mU/L × 100)
3.1 ± 1.3 2.9 ± 1.2 3.4 ± 1.4
LT (mL/min/kg  
per FFM)e
16.9 ± 3.9 16.6 ± 3.7 17.5 ± 4.5
Step counts  
(steps/day)
6486 ± 2637 7485 ± 2686 5264 ± 2108
Alcohol  
consumption  
(g/day)
7.3 ± 9.2 11.8 ± 9.6 1.8 ± 5.0c
Notes: Data are expressed as mean ± standard deviation; aP , 0.01, significantly 
different  versus  men;  bP  ,  0.001,  significantly  different  versus  men;  cP  ,  0.05, 
significantly different versus men; dn = 18 (9 females); en = 19 (8 females).
Abbreviations: BSA, body surface area; BMi, body mass index; %FAT, body fat 
percentage; VFA, visceral fat area; SFA, subcutaneous fat area; LDMA, low density 
muscle area; L/S, liver to spleen ratio; FFA, free fatty acids; hscrP, high sensitivity 
c-reactive  protein;  iL,  interleukin;  TnF,  tumor  necrosis  factor;  hMW,  high 
molecular weight; PAi, plasminogen activator inhibitor; Mcr, metabolic clearance 
rate; LT, oxygen uptake at the lactate threshold; FFM, fat-free mass.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
39
Fat deposition, aerobic capacity, and insulin sensitivity
for L/S; thus, L/S and LDMA explained 70% of the total 
variance in this model.
correlations between indices of fat 
accumulation and plasma parameters
As shown in Table 5, HMW adiponectin was significantly 
associated with %FAT and SFA, while IL-6 was significantly 
correlated with %FAT. TNF-α and PAI-1 levels were sig-
nificantly and negatively correlated with L/S as well as 
MCRG/IC, while hsCRP was negatively correlated with 
MCRG/IC. Surprisingly, none of the plasma parameters were 
associated with VFA or LDMA.
Discussion
This is the first study to evaluate associations among ectopic 
fat deposition in the liver and muscle, VF and SF   accumulation, 
aerobic capacity, and peripheral IS in a cohort of   Japanese 
subjects using insulin clamp techniques. The   findings of the 
study indicate that L/S and LDMA are significantly associ-
ated with peripheral IS independently of other indices of 
body fat accumulation and aerobic capacity in middle- to 
older-aged Japanese individuals with visceral adiposity.
Table 2 correlations among indices of body fat accumulation
VFA SFA LDMA L/S
%FAT ns 0.92a 0.65b ns
VFA ns ns ns
SFA 0.57b ns
LDMA ns
Notes: aP , 0.001; bP , 0.01.
Abbreviations: VFA, visceral fat area/body surface area; SFA, subcutaneous fat 
area/body surface area; LDMA, low density muscle area/mid-thigh area; L/S, liver to 
spleen ratio; %FAT, body fat percentage; ns, not significant.
Table 3 correlations among indices of fat accumulation, aerobic 
capacity, and insulin sensitivity
Index MCRG/IC
Unadjusted Model 1 Model 2 Model 3
%FAT ns ns ns ns
VFA -0.46a – ns ns
SFA ns ns ns ns
LDMA -0.57b -0.48a – -0.69b
L/S 0.70b 0.66b 0.78c –
LT ns ns ns ns
Notes: Model 1 is adjusted for VFA; Model 2 is adjusted for LDMA; Model 3 is 
adjusted for L/S; aP , 0.05; bP , 0.01; cP , 0.001.
Abbreviations: %FAT, body fat percentage; VFA, visceral fat area/body surface 
area; SFA, subcutaneous fat area/body surface area; LDMA, low density muscle area/
mid-thigh area; L/S, liver to spleen ratio; LT, oxygen uptake at lactate threshold; 
Mcrg/ic, metabolic clearance rate; ns, not significant.
Table 4 Multiple stepwise regression analysis for independent 
determinants of insulin sensitivity
R2 SEE F value P value
Step 1 L/S 0.47 0.13 17.2 ,0.001
Step 2 L/S + LDMA 0.70 0.10 21.7 ,0.001
Notes: Outcome variable: Mcrg/ic; independent variables: sex, age, %FAT, VFA, 
SFA, LDMA, L/S, LT, and alcohol consumption.
Abbreviations: %FAT, body fat percentage; VFA, visceral fat area/body surface 
area; SFA, subcutaneous fat area/body surface area; LDMA, low density muscle area/
mid-thigh area; L/S, liver to spleen ratio; LT, oxygen uptake at the lactate threshold; 
Mcrg/ic, metabolic clearance rate.
LDMA, whereas VFA and L/S were not significantly 
  correlated with other indices of fat accumulation.
correlations with iS
The correlations between indices of body fat accumulation, 
aerobic capacity and IS are shown in Table 3. Partial correla-
tion coefficient analysis was performed to adjust the effects 
of all fat accumulation and aerobic capacity parameters. 
In unadjusted models, VFA, LDMA, and L/S were signifi-
cantly correlated with MCRG/IC, which remained in adjusted 
models for LDMA and L/S, but not for VFA. In contrast, 
%FAT, SFA, and LT were not significantly correlated with 
MCRG/IC, even after adjusting for other factors such as VFA, 
LDMA, or L/S. In addition, L/S was significantly correlated 
with MCRG/IC, even after adjusting for alcohol consumption 
(r = 0.70, P , 0.01; data not shown) and all parameters 
(r = 0.74, P , 0.01; data not shown).
As shown in Table 4, multiple stepwise regression analy-
sis was performed to investigate the relative contribution of 
nine variables, namely sex, age, %FAT, VFA, SFA, LDMA, 
L/S, LT, and alcohol consumption, to MCRG/IC. This analysis 
showed that L/S was the main determinant of MCRG/IC, 
explaining 47% of the variance. A further 23% of the vari-
ance in MCRG/IC was attributed to LDMA after accounting 
Table  5  correlations  among  cytokines,  indices  of  body  fat 
accumulation, and insulin sensitivity
%FAT VFA SFA LDMA L/S MCRG/IC
FFA ns ns ns ns ns ns
hMW adiponectin 0.58a ns 0.54b ns ns ns
iL-6 0.56b ns ns ns ns ns
hscrP ns ns ns ns ns -0.57a
TnFα ns ns ns ns -0.67a -0.63a
PAi-1 ns ns ns ns -0.52b -0.58a
Notes: Mcrg/ic and cytokine concentrations were logarithmically transformed to 
approximate normal distributions; aP , 0.01; bP , 0.05.
Abbreviations: %FAT, percentage body fat; VFA, visceral fat area/body surface 
area; L/S, liver to spleen ratio; LDMA, low density muscle area/mid-thigh area; 
Mcrg/ic, metabolic clearance rate; FFA, free fatty acid; hMW adiponectin, high 
molecular  weight  adiponectin;  iL,  interleukin;  hscrP,  high  sensitivity  c-reactive 
protein; TnF, tumor necrosis factor; PAi-1, plasminogen activator inhibitor-1; ns, 
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A previous study revealed that the prevalence of insulin 
resistance and nonalcoholic fatty liver disease in a similar 
ethnic group of Asian-Indians was higher than that in age- 
and weight-matched White, Black, and Hispanic men.19 
However, the characteristics of participants in that study were 
very different to those of the present study (for example, age 
28.7 ± 8.3 versus 58.2 ± 9.3 years and BMI 22.4 ± 2.3 versus 
29.0 ± 4.1 kg/m2), limiting our ability to directly compare 
the two studies. Furthermore, differences in the risk of devel-
oping hepatic/skeletal muscle fat accumulation and its 
association with IS are not only due to race/ethnicity but also 
lifestyle (for example, physical activity and/or diet) and social 
factors. Indeed, the incidence rate of fatal coronary heart 
disease, which is strongly associated with glucose intolerance, 
in Japanese individuals living in Hawaii is approximately 
twice that in Japanese individuals living in Japan.20
Our results are consistent with those of earlier studies,1,3 
which indicate that L/S is associated with peripheral IS 
independently of other parameters of body fat accumulation 
in Japanese individuals with visceral adiposity. In addition, 
our study revealed that of various fat indices, liver fat is the 
most important determinant of IS. These results are consistent 
with the previous studies.21–23 However, in contrast to the 
present study, Kirchhoff et al21 reported that IS was associ-
ated with liver fat and VF, as well as SF. These different 
results might be due to the smaller range of values for param-
eters in the present study compared with those in the study 
by Kirchhoff et al.
The present study also showed that liver fat and cytokines 
PAI-1 and TNF-α were associated with IS. PAI-1 and TNF-α 
are associated with fat accumulation, particularly nonalco-
holic fatty liver disease.24–26 Furthermore, several studies 
have revealed that PAI-1 and TNF-α may directly contribute 
to insulin resistance.27,28 Our results are consistent with sev-
eral studies showing that insulin resistance is associated with 
an increase in circulating TNF-α and PAI-1 concentration.29,30 
Unexpectedly, the present study revealed that ectopic fat and 
IS were not associated with HMW adiponectin levels, 
whereas other studies have reported that HMW adiponectin 
was strongly associated with ectopic fat, IS, and metabolic 
syndrome.31,32 On the other hand, Petersen et al reported that 
muscle insulin resistance can arise independently of changes 
in circulating adipocytokine concentrations, particularly 
adiponectin, TNF-α, IL-6, and resistin.33 The relationships 
among cytokine levels, ectopic fat, and insulin resistance are 
still being debated, and more studies are clearly needed in 
this field.
Previous studies have proposed a relationship between 
VF and liver fat accumulation, as well as their associations 
with metabolic disease and insulin resistance.34,35 In this 
study, L/S was not significantly associated with VFA adjusted 
for BSA, although it was significantly associated with VFA 
calculated as an absolute value (that is, cm2; r = -0.45, 
P , 0.05). Similarly, Seppala-Lindroos et al reported no 
correlation between L/S and VFA.1 Although the reasons for 
these apparent discrepancies are unclear, it is possible that 
differences in the characteristics of the study populations, 
such as ethnicity, presence of diabetes or metabolic diseases, 
and general metabolic status will be potential factors. It is 
also possible that the methods used to determine VFA, and 
whether VFA is corrected for body size, are responsible for 
the differences between studies. We believe that it is impor-
tant to normalize VFA for BSA to provide more accurate 
comparisons between people of different sizes.
In terms of markers for metabolic dysfunction, Fabbrini 
et al reported that intrahepatic triglyceride content, but not 
visceral adipose tissue volume, is a marker for obesity-related 
metabolic dysfunction,36 while Petersen et al found no dif-
ference in the mean volume of intra-abdominal fat between 
lean insulin-resistant and BMI-matched insulin-sensitive 
subjects.37 However, considering that all the participants of 
the present study were viscerally obese, our findings may 
not apply for lean subjects.
Skeletal muscle is the primary site for the regulation of 
glucose metabolism in the human body.38 Intramyocellular 
fat causes a decline in IS, thus impairing glucose and lipid 
metabolism.4,5 Furthermore, several studies have suggested 
that decreases in IS are more strongly correlated with skeletal 
muscle fat deposition than with other indices of body fat 
accumulation.4,39,40 Interestingly, chronic exercise increases 
muscle lipid content and muscle IS, while reducing diacylg-
lycerol content.41 In fact, improvements in IS can be achieved 
by a single bout of exercise, with increases in the muscle 
concentrations of triglycerides and reduced concentrations of 
diacylglycerol.42 Similarly, another study revealed a signifi-
cant relationship between skeletal muscle fat deposition and 
an increase in physical activity.43 On the basis of these find-
ings, one may hypothesize that aerobic capacity and physical 
activity would be closely associated with IS. Here, we found 
that LDMA was negatively correlated with IS, %FAT, and 
SFA, but not with VFA. Surprisingly, LT was not significantly 
correlated with any of the indices of fat accumulation. Thus, 
the magnitude and type of associations between LDMA as a 
marker for skeletal muscle fat, aerobic capacity, and IS may Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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be affected by the type of fat and the extent of exercise; 
  subjects in our study were relatively sedentary according to 
their LT and daily step count. However, this differs from the 
findings reported by Kotronen et al, who reported that liver 
fat and aerobic capacity were related to muscle IS in normal 
to obese Finnish subjects aged 18–60 years.44 These differ-
ences might be explained as follows. First, we used LT as the 
index of aerobic capacity because the assessment of the 
maximum oxygen uptake (VO2 max) is often difficult in subjects 
with low aerobic capacity, particularly in elderly and obese 
subjects. Therefore, we used LT because it can be measured 
during a submaximal exercise test, and it is a reliable marker 
for aerobic capacity.45 Second, the aerobic capacity (LT) of 
our subjects was spread over a relatively narrow range, 
  limiting the extent of associations with other parameters.
This study has several limitations. First, the first and last 
measurements were taken a mean of 40.1 ± 6.8 days apart, 
and it is possible that fat deposition may change over this time. 
However, the subjects’ bodyweights did not change during 
this period, and any changes in liver fat and related metabolic 
parameters would be very small. Previous studies showed that 
neither liver fat nor bodyweight changed in a control group of 
subjects over a 4–6-week observation period.46,47 Second, two 
men consumed moderate amounts of alcohol (.20 g/day) for 
at least the preceding year, although alcohol intake was not 
excessively high (23 and 27 g/day). Even if we excluded these 
participants, the associations between IS and ectopic fat 
(LDMA, L/S) determined by correlation analysis (nonadjusted 
model and adjusted model) and multiple stepwise regression 
analysis were not affected. Third, fat in the liver and skeletal 
muscle were not assessed using magnetic resonance imaging 
or magnetic resonance spectrometry, two noninvasive methods 
that are more accurate than the methods used in this study. 
LDMA, a marker of lipid-rich skeletal muscle, was quantified 
using CT and cannot distinguish between extra- and intramyo-
cellular lipids.   Nevertheless, CT assessment of fat in liver and 
skeletal muscle shows high correlations with needle biopsy-
based assessment of tissue fat content.4,48,49 Fourth, this was a 
cross-sectional study of middle- to older-aged Japanese sub-
jects with VF accumulation but without marked metabolic 
disorders. Thus, these results may not be applicable to other 
groups of subjects, particularly younger subjects or those 
without visceral obesity. This design also limited our analysis 
to correlations, preventing assessment of causality or changes 
over time. Fifth, the sample size of this preliminary study was 
small (20 subjects) and included males and females, although 
we found no   significant relationship between IS and sex. On the 
other hand, we used a gold-standard technique – the 
euglycemic–  hyperinsulinemic clamp   technique – to determine 
IS in a quantitative manner, whereas other studies used less 
rigorous tests, such as tolerance tests and median values as 
cutoff values to define insulin resistance or IS. Furthermore, 
we attempted to minimize the influence of confounding vari-
ables such as sex and alcohol intake by performing multiple 
regression analysis, with the inclusion of these and other fac-
tors as possible influencing/confounding factors. Clearly, 
further studies in a larger cohort of subjects are needed to 
confirm our findings. Such studies should compare associations 
with IS in lean and obese subjects, physically active and inac-
tive subjects, and among different ethnic groups. Similarly, 
longitudinal cohort and interventional (for example, with 
weight loss interventions) studies would provide further insight 
into the associations between liver and skeletal muscle fat 
and IS, and the effects of changes in lifestyle factors on these 
associations.
In conclusion, the findings of this study indicate that 
ectopic fat deposition in the liver and skeletal muscle is 
associated with peripheral IS independently of indices of 
body fat accumulation and aerobic capacity in middle- to 
older-aged Japanese individuals with visceral adiposity. 
Although our study cannot reveal the underlying mecha-
nisms, our findings provide new insight as liver fat and 
cytokine levels (PAI-1 and TNF-α) were significantly associ-
ated with IS determined by euglycemic–hyperinsulinemic 
clamps in a cohort of Japanese subjects.
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